Structure of the proteasome

T Jung, T Grune - Progress in molecular biology and translational …, 2012 - Elsevier
The ubiquitin-proteasomal system is an essential element of the protein quality control
machinery in cells. The central part of this system is the 20S proteasome. The proteasome is …

Photoswitchable paclitaxel-based microtubule stabilisers allow optical control over the microtubule cytoskeleton

A Müller-Deku, JCM Meiring, K Loy, Y Kraus… - Nature …, 2020 - nature.com
Small molecule inhibitors are prime reagents for studies in microtubule cytoskeleton
research, being applicable across a range of biological models and not requiring genetic …

Class III β-tubulin mediates sensitivity to chemotherapeutic drugs in non–small cell lung cancer

PP Gan, E Pasquier, M Kavallaris - Cancer research, 2007 - AACR
First line therapy for non–small cell lung carcinoma (NSCLC) commonly includes
combination therapy with a tubulin-binding agent (TBA) and a DNA-damaging agent. TBAs …

Codelivery of doxorubicin and paclitaxel by cross-linked multilamellar liposome enables synergistic antitumor activity

Y Liu, J Fang, YJ Kim, MK Wong… - Molecular …, 2014 - ACS Publications
Combining chemotherapeutics is a promising method of improving cancer treatment;
however, the clinical success of combination therapy is limited by the distinct …

Co-delivery of doxorubicin and paclitaxel via noisome nanocarriers attenuates cancerous phenotypes in gastric cancer cells

N Rezaei, MK Arki, Z Miri-Lavasani, R Solhi… - European Journal of …, 2023 - Elsevier
Gastric cancer (GC) is known as a deadly malignancy all over the world, yet none of the
current therapeutic regimens have achieved efficacy. this current study has aimed to …

A hindsight reflection on the clinical studies of poly(l‐glutamic acid)‐paclitaxel

J Zhao, EJ Koay, T Li, X Wen… - Wiley Interdisciplinary …, 2018 - Wiley Online Library
Chemotherapy for cancer treatment is limited by the excessive toxicity to normal tissues. The
design of chemodrug‐loaded nanoformulations provides a unique approach to improve the …

Chemodrug delivery using integrin-targeted PLGA-Chitosan nanoparticle for lung cancer therapy

A Babu, N Amreddy, R Muralidharan, G Pathuri… - Scientific reports, 2017 - nature.com
In this study, we report the efficacy of RGD (arginine-glycine-aspartic acid) peptide-modified
polylactic acid-co-glycolic acid (PLGA)-Chitosan nanoparticle (CSNP) for integrin αvβ3 …

Paclitaxel-induced apoptosis in BJAB cells proceeds via a death receptor-independent, caspases-3/-8-driven mitochondrial amplification loop

C von Haefen, T Wieder, F Essmann, K Schulze-Osthoff… - Oncogene, 2003 - nature.com
Caspase-8 is a key effector of death-receptor-triggered apoptosis. In a previous study, we
demonstrated, however, that caspase-8 can also be activated in a death receptor …

Cajanol, a novel anticancer agent from Pigeonpea [Cajanus cajan (L.) Millsp.] roots, induces apoptosis in human breast cancer cells through a ROS-mediated …

M Luo, X Liu, Y Zu, Y Fu, S Zhang, L Yao… - Chemico-Biological …, 2010 - Elsevier
Cajanol (5-hydroxy-3-(4-hydroxy-2-methoxyphenyl)-7-methoxychroman-4-one) is an
isoflavanone from Pigeonpea [Cajanus cajan (L.) Millsp.] roots. As the most effective …

Drug-eluting stents: sirolimus and paclitaxel differentially affect cultured cells and injured arteries

TJ Parry, R Brosius, R Thyagarajan, D Carter… - European journal of …, 2005 - Elsevier
Sirolimus and paclitaxel eluted from stents inhibit cell proliferation and other cellular
processes by dramatically different mechanisms. In this study, the effects of sirolimus and …